Tue.Aug 13, 2024

article thumbnail

To approve Amgen's lung cancer med Imdelltra, FDA saw past 'large number' of missing adverse events

Fierce Pharma

When the FDA approved Amgen’s Imdelltra in May, the T-cell engager was hailed as a breakthrough for the treatment of small cell lung cancer (SCLC) and as the first DLL3-targeting therapy of potenti | In granting an accelerated approval to Amgen's first-in-class DLL3 bispecific Imdelltra, the FDA had to work through a “large number” of missing adverse events from a pivotal trial.

FDA 322
article thumbnail

Remembering Paul Bannister, dear friend and finance manager

pharmaphorum

Our longtime Finance Director Paul Bannister was a part of the fabric of pharmaphorum almost from the beginning and an integral part of keeping the publication running. And, most importantly, he was the soul of the place and a friend to all.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Lexicon to lay off 50% of field force as it prioritizes heart failure drug, potential US diabetes launch

Fierce Pharma

Despite winning an FDA approval in 2023 and gaining clarity in May on the regulatory path forward for its Type 1 diabetes prospect sotagliflozin, Lexicon Pharmaceuticals hasn’t had an easy go of it | As part of a restructuring initiative, Lexicon Pharmaceuticals will lay off more than 75 staffers, or approximately 50% of its current field force, by the end of September.

article thumbnail

4 Things to Know About the McLaren Cyberattack & Its Aftermath

MedCity News

Last week, McLaren Health Care fell victim to its second major cyberattack in less than a year. The Michigan-based health system has been working to restore its IT and phone systems over the past week, but some of these systems still remain down. The post 4 Things to Know About the McLaren Cyberattack & Its Aftermath appeared first on MedCity News.

110
110
article thumbnail

AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

article thumbnail

CORRECTED: After icodec rejection, Novo Nordisk won’t file application for once-weekly insulin and semaglutide combo in US

Fierce Pharma

CORRECTED: After icodec rejection, Novo Nordisk won’t file application for once-weekly insulin and semaglutide combo in US fkansteiner Tue, 08/13/2024 - 13:42

235
235
article thumbnail

People need to know how to use AI now

pharmaphorum

With the implementation of advancing technologies in industry comes the parallel need for suitable upskilling of the workforce – but this doesn’t as yet always pan out, and in today’s pharmaphorum podcast COO of Enthought Mike Connell discusses the growing skills gap in R&D in life sciences and the 80/20 rule with web editor Nicole Raleigh, as well as the need for correct education of people and machines, both.

Education 112

More Trending

article thumbnail

Private Equity Buys Another Piece of Baxter as Carlyle Scoops Up Kidney Care Biz for $3.8B

MedCity News

Baxter International is selling its kidney care business for less than it was able to fetch for its much smaller biopharma solutions segment last year. A unit within kidney care took a goodwill impairment charge, Baxter’s financial reports show. The post Private Equity Buys Another Piece of Baxter as Carlyle Scoops Up Kidney Care Biz for $3.8B appeared first on MedCity News.

Biopharma 110
article thumbnail

Investor activism resurfaces at Aurinia after CEO’s board role, exec pay lost majority support

Fierce Pharma

A deal to bring back former CEO Robert Foster, Ph.D., didn’t completely quell investors’ concerns about Aurinia Pharmaceuticals. | A deal to bring back former CEO Robert Foster, Ph.D., didn’t completely quell investors’ concerns about Aurinia Pharmaceuticals.

article thumbnail

Modern Health Boosts AI Capabilities by Acquiring Anvil Health’s Tech

MedCity News

Modern Health has acquired Anvil Health’s AI technology. It has also hired Anvil’s co-founder, Paul Clark, as head of AI strategy. The post Modern Health Boosts AI Capabilities by Acquiring Anvil Health’s Tech appeared first on MedCity News.

108
108
article thumbnail

Itching for leadership in 'therapeutic dermatology,' Galderma wins FDA nod for Nemluvio to treat prurigo nodularis

Fierce Pharma

Itching for leadership in 'therapeutic dermatology,' Galderma wins FDA nod for Nemluvio to treat prurigo nodularis kdunleavy Tue, 08/13/2024 - 10:38

FDA 130
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Remembering Paul Bannister, our dear friend and finance manager

pharmaphorum

On Sunday 28th July, pharmaphorum lost a much-beloved member of the family. If you don’t work for or with pharmaphorum or Healthware, you probably don’t know the name Paul Bannister. Paul wasn’t a writer or a designer or a photographer. He never had a byline on the website. He didn’t interface with sponsors or advertisers.But as our longtime Finance Director, he was a part of the fabric of the company almost from the beginning and an integral part of keeping the publication running.

article thumbnail

INVEST Digital Health Pitch Perfect Judge Shares Healthcare Startup Investment Insights

MedCity News

Dan Easton, Unorthodox Ventures Principal, is one of the judges for the INVEST Pitch Perfect startup contest, which will focus on pediatric mental health. In response to emailed questions, Easton shared the firm’s approach to healthcare startups. The post INVEST Digital Health Pitch Perfect Judge Shares Healthcare Startup Investment Insights appeared first on MedCity News.

article thumbnail

FDA approves Ascendis Pharma’s YORVIPATH for hypoparathyroidism

Pharmaceutical Technology

Ascendis Pharma has obtained US Food and Drug Administration (FDA) approval for its YORVIPATH to treat hypoparathyroidism in adults.

article thumbnail

How Digital Delivery Can Empower Staff and Shape the Future of Pharmacy 

MedCity News

if we can shift the way we deliver information, we can change the entire culture of pharmacy in a way that relieves some of the burden on the pharmacists and improves patient outcomes at the same time. The post How Digital Delivery Can Empower Staff and Shape the Future of Pharmacy appeared first on MedCity News.

Patients 104
article thumbnail

How to Prove Marketing Value: Demonstrate Content ROI and Contribution to Sales

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

article thumbnail

A biotech’s difficult journey to bring a new kind of Parkinson’s drug to patients

PharmaVoice

A series of executive turnovers at Gain Therapeutics this year precedes important early-stage Parkinson’s results that could change how the disease is treated.

article thumbnail

What’s Keeping Healthcare CIOs Up at Night: How to Improve Patient Satisfaction by Handling Calls More Efficiently

MedCity News

Health systems have spent billions on portals while investments in modernizing the voice channel — the dominant preference of healthcare consumers — have taken a backseat. The post What’s Keeping Healthcare CIOs Up at Night: How to Improve Patient Satisfaction by Handling Calls More Efficiently appeared first on MedCity News.

article thumbnail

Judge rebuffs Novartis bid to block generic Entresto

pharmaphorum

Novartis' attempt to stop MSN Pharma from launching a generic version of heart failure blockbuster Entresto is blocked in a US court

Pharma 85
article thumbnail

To Advance Health Equity, We Must Stop Shaming Fax

MedCity News

The disdain for fax in all its forms isn’t new. But at a time when small healthcare organizations struggle to afford an EHR, the question remains: Who are the digital haves to judge the digital have-nots? The post To Advance Health Equity, We Must Stop Shaming Fax appeared first on MedCity News.

article thumbnail

Optimizing Clinical Supply Strategy: Navigating Challenges & Finding Your Ideal Model

article thumbnail

Why You Shouldn't Blindly Trust Google to Automate Your Google Ads Account

Healthcare Success

As a leading Google Premier Partner managing millions of dollars in annual Google Ads spend, we strongly advocate for the platform. Our digital team collaborates closely with Google's enterprise team to implement best practices for all our clients. However, we’ve discovered that not all Google recommendations are equally effective. Many of our new clients come to us with ad campaigns that over rely on Google's automated solutions, resulting in costly performance problems.

article thumbnail

A potential MS ‘game changer’ could bring more safety to the table — even against viruses

PharmaVoice

Immunic’s treatment has anti-inflammation, neuroprotection and antiviral effects plus a ‘benign’ safety profile that even seems to lower the risk of COVID-19 infection.

Safety 65
article thumbnail

FDA okays Ascendis hypoparathyroidism drug at second attempt

pharmaphorum

After turning it down a year ago, the FDA has cleared once-daily injectable Yorvipath for hypoparathyroidism from Ascendis Pharma.Yorvipath (palopegteriparatide) – previously known as TransCon PTH – has been approved to treat adults with hypoparathyroidism, a rare condition defined by a deficiency of parathyroid hormone (PTH) that affects 70,000 to 90,000 people in the US.

FDA 64
article thumbnail

CMT Research Foundation invests in research project to develop treatments for CMTs

PharmaTimes

The rare, peripheral neuropathy disease affects nearly three million people globally

88
article thumbnail

Increase Revenue With Better, Faster Sales Onboarding

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

article thumbnail

Digital health fund makes debut with $21m for startups

pharmaphorum

A group of healthcare industry veterans have launched a new investment fund – called Create Health Ventures – with $21 million in the pot to support early-stage companies with tech that can support payers and pharma companies.

Pharma 64
article thumbnail

Pharma Pulse 8/13/24: How Should Biotechs Strategize for 2025, Pfizer Announces Top-Line Results of ABRYSVO for RSV & more

Pharmaceutical Commerce

The latest news for pharma industry insiders.

Pharma 105
article thumbnail

Francis Crick scientists reveal how cells ‘raise the alarm’ when damaged or infected

PharmaTimes

The V-ATPase protein, V1H, was found to be involved in the process of raising the alarm

84
article thumbnail

Digital health fund makes debut with $21m for start-ups

pharmaphorum

New digital health fund Create Health Ventures debuts with $21m to support start-ups with enabling tech for payers and pharma companies.

Pharma 64
article thumbnail

European Clinical Supply Planning: Balancing Cost, Flexibility and Time

article thumbnail

First Nasal Spray for Anaphylaxis Approved by FDA

PharmaTech

The epinephrine nasal spray was approved for the emergency treatment of type 1 allergic reactions in adults and children.

FDA 69
article thumbnail

Galderma gets FDA nod for prurigo nodularis therapy

pharmaphorum

Galderma has FDA approval for prurigo nodularis treatment Nemluvio, one of two new drugs that it thinks will deliver blockbuster sales

FDA 64
article thumbnail

The Role of the BC Doctors Directory in Improving Patient-Doctor Connections

Scott’s Directories

Establishing strong patient-doctor connections is vital for effective healthcare delivery in British Columbia. With the increasing demand for personalized care, patients need quick access to medical professionals who can address their health needs. The BC Physician Directory significantly bridges this gap, ensuring patients can easily find the right healthcare provider.

Doctors 52
article thumbnail

Salesforce for Sales Reps: Pros, Cons, and a Superior Alternative

Spotio

CRM software is an essential tool for most sales reps. Once you and your team are set up with the right platform, you’ll be able to pinpoint prospect details, track pipeline, facilitate communication with potential customers, and otherwise manage your list of contacts. The biggest name in CRM is Salesforce. The company has been around the longest and offers an extensive set of features.

Sales 52
article thumbnail

Using Generative AI in Sales: Pros, Cons, and Considerations According to Sellers

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A